Scientific Program
The latest updates by world-renowned experts in the field of diabetes
We are planning an innovative and exciting program for ATTD 2021. The full program will be available shortly.
Review the confirmed topics and speakers below.
*Updated as of 16 November, 2020
| First Name | Last Name | Country | Topic |
|---|---|---|---|
| Michael | Abràmoff | USA | Autonomous Artificial Intelligence and Diabetic Retinopathy: Safety, Efficacy and Equity |
| Jeffrey | Alfonsi | Canada | Together with Mark Palmert – iSpy: Novel Carbohydrate Counting Smartphone App for Youth with Type 1 Diabetes |
| Stephanie | Amiel | UK | From Hesiod to Hollywood: getting the best blood glucose for rational thinking |
| Katharine | Barnard | UK | Together with Korey Hood: Patient Related Outcomes (PROs) – presentation of key instruments and how to use them (INSPIRE measures) |
| Richard | Bergenstal | USA | Use of technology for the treatment of type 2 diabetes |
| Stephane | Bidet | France | Artificial Intelligence applications to support decision management in insulin therapy |
| Bruce | Bode | USA | Management of glucose in the hospital using computerized systems |
| Stefan | Bornstein | Germany | Novel medications for diabetes to be used during COVID-19 pandemic |
| Charlotte | Boughton | UK | Broadening usage of closed-loop |
| Nataša | Bratina | Slovenia | Impact of patient reported outcomes on pediatric routine clinical work |
| Katarina | Braune | Germany | Patient-centered innovation in healthcare |
| Bruce | Buckingham | USA | A pivotal trial of Omnipod Horizon™ Automated Glucose Control System |
| Fergus | Cameron | Australia | Debate: In the era of remote visits – do we still need A1c measures Stuart Weinzimer – CON Fergus Cameron – PRO |
| Anders | Carlson | USA | Performance of studies on advanced hybrid closed-loop 780G |
| Antonio | Ceriello | Italy | How to manage type 2 diabetes and obesity during the COVID-19 pandemic |
| Pratik | Choudhary | UK | Transplantation – managing partial pancreas function or managing the failing pancreas |
| Mark | Clements | USA | What do we need to develop/improve with the technology that we are using today |
| Kelly | Close | USA | Harnessing the power of social media and peer support |
| Thomas | Danne | Germany |
|
| Christophe | De Block | Belgium | NAFLD/NASH in type 1 diabetes: overrated or underappreciated |
| Carine | de Beaufort | Luxembourg | COVID-19 outbreak and Pediatric diabetes |
| Elisa | De Franco | UK | Update on genes for Neonatal Diabetes |
| Hans | DeVries | The Netherlands | New insulins: Foreseeable impact on diabetes therapy – Once weekly insulins |
| Klemen | Dovc | Slovenia |
|
| Francis | Doyle III | USA | Update on Artificial Pancreas engineering and clinical studies |
| David | Dunger | UK | Innovative trial design in INNODIA |
| Steven | Edelman | USA | Strategies for improvement of metabolic control in adults with T1D |
| Denice | Feig | Canada | DEBATE: Should all pregnant women with diabetes take metformin during pregnancy Yariv Yogev – CON Denice Feig – PRO |
| Satish | Garg | USA | Managing T1D-new-onsets and DKA through telehealth |
| Ahmad | Haidar | Canada | multi-hormone closed-loop systems |
| Michael | Haller | USA | Using tele-education with the ECHO model to reach primary care providers in rural areas to improve the level of care for people with diabetes |
| Tim | Heise | Germany | New insulins: Foreseeable impact on diabetes therapy – Smart Insulins |
| Pau | Herrero | UK | Artificial Intelligence upgrades automated insulin delivery towards a fully closed-loop |
| Irl | Hirsch | USA |
|
| Korey | Hood | USA |
|
| Roman | Hovorka | UK | Use of the CamAPS FX closed-loop in the research and clinical investigation |
| Peter | Jacobs | USA | Decision support and closed loop control during exercise: new findings from clinical studies and larger data sets |
| Partha | Kar | UK | Where two worlds collide: how social media and peer support can enhance clinical care |
| Boris | Kovatchev | USA | Results of a study on Closed-Loop Control (CLC) system – Control IQ |
| Lori | Laffel | USA |
|
| Robert | Lindsay | UK | Factors associated with stillbirth in women with diabetes |
| David | Maahs | USA | NIH funded study: Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Study |
| Chantal | Mathieu | Belgium | Introduction INNODIA/INNODIA HARVEST study |
| Laurel | Messer | USA | Artificial pancreas device upgrades—best practices for onboarding and follow-up |
| Othmar | Moser | Austria | EASD/ISAP position statement on CGM/exercise in type 1 diabetes |
| Helen | Murphy | UK | Pregnancy outcomes of 17,375 women with diabetes: National population-based cohort study |
| Omar | Mustafa | UK | Glucose control during COVID-19 infection: targets and acute derangements |
| Steven | Nissen | USA | Dual or triple GLP/GIPs as treatment for T2D |
| Simon | O’Neill | UK | Diabetes UK – T2D perspective |
| Mark | Palmert | Canada | Together with Jeff Alfonsi – iSpy: Novel Carbohydrate Counting Smartphone App for Youth with Type 1 Diabetes |
| Susana | Patton | USA | Intervening on Hypoglycemia Fear in Parents of Young Children using Direct-to-Home Video-based Telehealth |
| William | Polonsky | USA | Impact of PROs on adult clinical care: why, when and how? |
| Walter | Pories | USA | Toxic Intestinal signals as a cause of type 2 diabetes and the metabolic syndrome |
| Eric | Renard | France | Efficacy of Closed-loop Insulin Therapy in Adults Prone to Hypoglycemia – the International Diabetes Closed-Loop Trial Protocol 2 |
| Michael | Riddell | Canada | Monitoring the elite athlete with type 1 |
| Francesco | Rubino | UK | An international register for new onset diabetes during COVID-19 pandemic |
| Andrea | Scaramuzza | Italy | Benefits and challenges of diabetes technology in children |
| Desmond | Schatz | USA | Lessons from the nPOD |
| Anke | Schulte | Germany | An integrated search for novel biomarkers |
| Eleanor | Scott | UK | Week by week CGM profiles of pregnant women with type 1 diabetes |
| Jay | Skyler | USA |
|
| Amir | Tirosh | Israel | Virtual Diabetes Clinic – the Dietitian Perspective |
| Maria | Vasiloglou | Switzerland | Comparison of novel and traditional dietary assessment methods in diabetes patients |
| Stuart | Weinzimer | USA | Debate: In the era of remote visits – do we still need A1c measures Fergus Cameron – PRO Stuart Weinzimer – CON |
| Emma | Wilmot | UK | The effectiveness of isCGM: comparison of data from RCTs and routine-use |
| Yariv | Yogev | Israel | DEBATE: Should all pregnant women with diabetes take metformin during pregnancy CON – Yariv Yogev PRO – Denice Feig |
| Eric | Zijlstra | Germany | New insulins: Foreseeable impact on diabetes therapy – Oral Insulin |